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Abstract
Background: Symptomatic spinal metastasis from an intracranial primary
glioblastoma multiforme (GBM) is very rare. Our literature search identified a total
of 42 such patients of which 11 were treated with surgical decompression for spinal
metastasis with only one such report from the pediatric age group. Previous studies
have reported variable outcomes after surgical management.
Case Description: We report the case of a 16‑year‑old boy who underwent
surgical spinal decompression for spinal metastasis after intracranial GBM. The
patient regained motor and autonomic function following surgery and reported
improvement in pain. We also present findings from a literature review using the
PubMed database from 1985 to June 2013 on this subject and compare radiation
therapy with surgical decompression as palliative modalities in such patients.
Conclusion: There are no evidence‑based guidelines available on the subject
and no treatment regimen has yet demonstrated survival benefit in these patients.
Surgical decompression may be a better option for patients with focal resectable
lesions and who are medically stable to tolerate the procedure.
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INTRODUCTION
Glioblastoma multiforme (GBM) is the most common
primary malignant brain tumor.[3,22] It arises mostly from
astrocytes but may also derive from oligodendrocytes.[11]
The peak incidence is at 54 years of age and increases
thereafter.[11] The incidence among 18‑ to 24‑year‑olds
is about 1 per million and it is even lesser in younger
children.[11] The reported incidence of extra cranial
metastasis in these tumors is between 0.4% and 0.5%.[15]
Leptomeningeal and spinal metastasis are even rarer with

a relatively poor prognosis.[12,21,24] Our literature search
identified a total of 42 reported cases of spinal drop down
metastasis following GBM and only 11 of these patients
underwent a surgical spinal decompression. There has
only been one such case reported from the pediatric age
group.[11] We report the case of a 16‑year‑old boy who was
initially diagnosed and treated for a left parietooccipital
GBM and then developed spinal metastasis for which
he underwent surgical spinal decompression. We also
review the literature on the efficacy of spinal surgical
decompression on clinical outcomes in these patients and
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report and compare outcomes in patients who received
surgical decompression with those who did not.

CASE REPORT
This 16‑year‑old male child presented with spontaneous
onset of headache, nausea, and slight drowsiness
since 2 weeks. The neurological examination revealed
intact higher mental functions and no cerebellar
signs. However, there was a bitemporal heteronymous
hemianopia confirmed by perimetry. Power in right
upper and lower limb was 4/5 according to Medical
Research Council (MRC) scale with positive pronator
drift.[17] The gait was otherwise normal. Magnetic resonance
imaging (MRI) showed a left parietooccipital lesion with
intraventricular extension [Figure 1]. Both solid and cystic
components were present with calcifications marked on
the medial aspect. The patient underwent a craniotomy
with neuronavigation‑guided biopsy of the mass and gross
total excision. Intraoperatively, a soft‑firm mildly vascular
lesion was identified, which was clearly demarcated in
most dimensions. A frozen section confirmed the diagnosis
of World Health Organization (WHO) grade IV GBM and
this was consistent with the final histopathology report.
The tumor was Glial fibrillary acidic protein (GFAP)
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Figure 1: (a) CT scan head; (b-d) T1-contrast enhanced MRI showing
a left parietooccipital lesion with intraventricular extension. Both
solid and cystic components can be appreciated with calcifications
on the medial aspect
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and s‑100 positive and 40% of the cells showed
nuclear positivity with MIB‑1 antibody to the Ki‑67
antigen (MIB‑1). Postoperatively, the patient developed
a subtle sensory aphasia. The rest of the hospital course
was unremarkable and the patient was discharged in
stable condition. The patient received postoperative local
radiotherapy with a total dose of 54 grays (Gy).
Eight months later the patient presented with acute onset
bilateral lower limb paraplegia. There was a complete
loss of sensation in dermatome thoracic 7 (T‑7) and T‑8.
Abdominal and cremasteric reflexes were absent. The
power was 0/5 with increased spasticity and 3+ reflexes
and normal bulk in both the lower limbs.[17,25] The
Babinski’s sign was positive bilaterally and the patient
had lost bladder control. An MRI showed recurrence
of GBM with multifocal cranial deposits [Figure 2]
and spinal MRI showed an intradural extramedullary
mass measuring 1.1 × 5.0 cm in anterioposterior (AP)
and craniocaudal dimensions at T‑5 to T‑7 level with
significant cord compression [Figure 3].
The patient underwent a T5‑T7 laminectomy and excision
of metastatic mass. Intraoperatively, a fragile highly vascular
intradural extramedullary mass was noticed and sent for
histopathology analysis. The histopathological examination
of the mass revealed multiple fragments of a cellular
tumor with hemangiopericytomatous vasculature. The cells
revealed hyperchromatic round to oval nuclei with scant
cytoplasm [Figure 4]. Increased mitotic figures and glycogen
were also seen. On immunohistochemical staining, the
mass was focally positive for GFAP, epithelial membrane
antigen (EMA), cluster of differentiation 99 (CD 99) and
Vimentin [Figure 5]. The MIB‑1 was raised and a diagnosis
of metastatic GBM was made. Postoperatively, the patient
showed recovery of autonomic function and the power
was 3/5 in both the lower limbs, which gradually improved
to 5/5 over the next one month. The patient was given
postoperative radiotherapy with a total dose of 28 Gy.
Three months later, the patient presented to the
emergency room (ER) with fever of 39°C and seizures
since 3 days. He also complained of urinary and fecal
incontinence. We evaluated him for these complaints
with urine culture, which grew Escherichia coli and
Psuedomonas and the patient was given appropriate
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Figure 2: (a-c) T1-contrast enhanced MRI head performed 6 months postoperatively suggestive of recurrent disease
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Figure 3: (a) Sagittal section T-2 MRI showing lesion at T5-T7
levels resulting in significant cord compression. (b) Axial section
T-2 MRI (with magnification tool of PACS) showing an intradural
extra-medullary mass compressing the spinal cord

supportive care and antibiotics and discharged from the
hospital once in stable condition.
Three weeks later, the patient presented with severe
pain in right arm and loss of sensation, which now
involved both the upper arms. The family signed a do
not resuscitate (DNR) form and the patient passed
away 2 days later following cardiopulmonary arrest after
significant brain stem herniation and extension of GBM.

DISCUSSION
The incidence of symptomatic spinal metastasis from a
primary intracranial metastasis has been reported between
1% and 2.7%.[2,21,24] The exact number maybe even higher
as GBM is a rapidly progressive disease in which many
patients probably die before spinal metastasis become
symptomatic. Technological advances have slightly
improved the life expectancy of patients with GBM and
increased use of MRI may lead to a higher incidence
being reported in the future.
The exact mechanism for intramedullary spread
remains unclear.[20] A probable pathway of dissemination
includes invasion of the basement membrane and
choroid plexus. This theory is supported by reports in
literature where increased incidence is associated with
tumor presence proximal to ventricular structures and
craniotomies.[7] However, dissemination has been known
to occur even without a craniotomy[1,10,16] and many studies
have found that tumor proximity to ventricular system is
not an independent risk factor for spinal metastasis.[6,20]
The immunocompromised status from adjuvant radiation
and chemotherapy may render these patients more prone
to metastatic disease.[20] The spread of GBM has also
been reported along white matter tracts.[8] Mutations in
the tumor suppressor gene PTEN, higher MIB‑1 labeling
index and GFAP expression have been associated with a
higher risk for intramedullary metastasis.[13,15,20] Neurological
symptoms such as back pain, gait disorders, sensory and
motor deficits are common in patients with drop metastasis
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Figure 4: Sheets of atypical cells with hyperchromatic nuclei and
increased mitosis (H and E stain, ×400)

and depend on the segment of the cord affected and the
long tracts, which are compromised.[23] The most common
neurological deficit is paraperesis.[23] Spinal metastasis is
reported to occur 5-13 months after the diagnosis of primary
intracerebral glioma.[10,21] The median time from diagnosis
of GBM to death is less than 2 years.[20] The median
time from diagnosis of spinal metastasis to death was one
month, with only one patient surviving for 5 months.[21]
Our patient passed away within a year of diagnosis of GBM
and about 4 months after symptomatic spinal metastasis,
which is consistent with reports in literature.
The overall survival after a diagnosis of GBM has only
marginally improved over the decades. The addition of
temozolomide has improved the 5 year survival rate to about
10% as opposed to 1.9% with radiation alone.[22] Despite
temozolamide, 70% of the patients die within 2 years
of diagnosis.[22] Our patient did not receive adjuvant
chemotherapy with temozloamide despite recommendation
because of financial constraints. This raises questions as to
the extent of palliative measures that should be adopted
in resource‑deprived developing countries and severely
hampers our ability to care for these very sick patients.
Consensus exists that younger age and good neurological
status at presentation confer better outcomes.[21] Adjuvant
chemotherapy, radiotherapy, and total tumor resection
have been shown to increase life expectancy in patients
with GBM.[21] The molecular genetics of GBM may be the
most important determinant of patient outcomes. Patients
with O6‑methylguanine‑DNA methyltransferase (MGMT)
promoter methylation have a 2‑year survival of 48.9% and
5‑year survival of 13.8%, as compared with 14.8% and 8.3%,
respectively, among those with unmethylated MGMT.[14]
Many authors have recommended the use of
steroids.[20,23] We also administered steroids to our
patient. The outcomes following steroid administration
are variable and mostly depend on the outcomes of
adjuvant radiotherapy and treatment with temozolomide.

Surgical Neurology International 2014, 5:40

http://www.surgicalneurologyint.com/content/5/1/40

However, it seems reasonable to use steroids in acute
settings till appropriate guidelines become available.
At present no evidence‑based radiation schedule exists
for spinal metastasis of GBM.[23] Authors have previously
described using radiation doses of 20, 21, 30, and 39 Gy.
This has generally been of limited advantage in terms
of regaining lost function or survival benefit.[10,12,19,20,23]
However, some authors have reported good palliative
outcomes in terms of pain relief.[12]
Surgical spinal decompression with laminectomy has only
been described in some case reports[4,5,9,11,23,24] [Table 1].

Figure 5: The tumor cells are diffusely positive for GFAP
immunostain (×400)

Out of the 11 cases that we found during our literature
search, there were 5 male and 5 female patients (gender of
1 patient was not mentioned). The median age at the time
of surgery was 34 years (inter‑quartile range; IQR = 43.5).
Three patients received chemotherapy for their spinal
metastasis, while eight patients received radiation therapy.
Overall, good palliative outcomes were described in
six (54.5%) patients, three (27.3%) patients did not have
improvement in symptoms, while the outcomes could not
be determined for two (18.2%) patients. At the same time,
we identified 31 patients who received radiation therapy
or concomitant chemoradiotherapy (CCRT) for their
spinal metastasis. Out of these 31 patients, pain relief was
significant in only 6 patients (19.4%), no improvement was
noticed in 16 patients (51.6%), while outcomes could not
be determined for 9 patients (29%). In comparison, less
than 20% of the patients who underwent radiation therapy
alone reported improvement in symptoms. Our patient
also reported significant improvement in symptoms
following a surgical spinal decompression. However, this
sample size is too small for any meaningful statistical
analysis. Moreover, the reports are compiled over more than
25 years and the efficacy of radiation and chemotherapy
has changed over time. Also there may be a selection bias
favoring those patients for surgical decompression who
have focal resectable lesions and are in a relatively better
medical condition. In our opinion, treatment should be
individualized for every case till uniform evidence‑based
guideline becomes available on the subject.

Table 1: Previous reports of spinal metastasis with GBM and outcomes[2,4,5,9‑11,18,23,24]
Author (year)

Age (sex) Spinal segment
effected

Khan et al. (current report)

16, M

Amitendu et al., 2012

63, F

Tinchon et al., 2012
Arzbaecher et al., 2007

27, M
Not
known
63, F

Jahraus et al., 2003

6, F

Hubner et al., 2001

36, F

Hamilton et al., 1993

70, M

Vertosick et al., 1990
Onda et al., 1986

21, F
42, M

Bukeo et al., 1985

32, M

GBM: Glioblastoma multiforme

Thoracic

Symptoms

Paraplegia, loss of sensation in
T7‑T8
Lumbar
Bilateral sciatica, lower limb
weakness, lower limb weakness
Sacral
Right sided sciatica
Thoracic
Paraparesis, autonomic dysfunction
and sensory level
Thoracic
Paraplegia, T6 sensory level,
absent lower extremity reflexes,
gait ataxia, and bowel incontinence
Cervical, Thoracic Bilateral lower extremity
and Lumbar
paraperesis
Cervical, Lumbar Paraparesis, Bladder incontinence
and Sacral
Thoracic
Urinary incontinence, paresthesia
and lower limb weakness, sensory
level at T10
Thoracic
Paraparesis
Cervical
Weakness of lower extremities,
flaccid paraplegia, sensory
impairment below T9, dysuria
Thoracic
Paraplegia, urinary incontinence

Chemotherapy Radiotherapy Improvement
in symptoms
No

Yes

Yes

No

No

Yes

No
Yes

No
Yes

Yes
Yes

Yes

Yes

No

Yes

Yes

No

No

No

Unknown

No

Yes

Yes

No
No

Yes
Yes

No
Unknown

No

Yes

Unknown
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CONCLUSION
No evidence‑based guidelines have yet been developed
due to the rare incidence of spinal metastasis from a
GBM and no treatment regimen has yet demonstrated
survival benefit. Treatment modalities need to be
individualized to the needs and resources of the patients
and hospitals. Surgical decompression may be a better
option for patients with resectable focal lesions who are
medically stable to tolerate the procedure.
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